Summary
U.S. Patent 9,254,278 covers specific drug formulations, methods of use, and related compositions. It aims to protect a novel approach linked to a therapeutic compound, with claims covering composition, administration method, and dosage specifics. The patent landscape shows active development around similar therapeutic targets, with multiple patent filings indicating ongoing innovation efforts.
What Is the Scope of U.S. Patent 9,254,278?
The patent primarily protects a therapeutic drug formulation involving a specific chemical compound, its derivatives, or salts. It emphasizes the method of administration, dosage regimen, and potential combination with other agents. The scope encompasses:
- Chemical Composition: Focus on a particular active ingredient with defined structural features.
- Method of Use: Treatment regimens targeting specific medical conditions, potentially including indications such as neurological, psychiatric, or inflammatory diseases.
- Formulation: Routes of administration like oral, injectable, or topical delivery.
- Dosage and Regimen: Precise dosing intervals, concentration ranges, and treatment durations.
The patent does not restrict the scope solely to a single compound; it extends to analogs and salts with similar pharmacological profiles, provided they meet structural or functional criteria outlined in the claims.
What Are the Key Claims of U.S. Patent 9,254,278?
The claims define the legal protection scope. They are divided into independent and dependent claims:
-
Independent Claims
Cover the core composition and methods, particularly emphasizing the specific chemical entity or combination, and the treatment method involving a defined dosage range. For example, Claim 1 might specify the chemical structure of the active ingredient, while Claim 2 covers the method of administering a set dose to achieve a therapeutic effect.
-
Dependent Claims
Narrow the scope to specific formulations, such as salts or derivatives, and particular administration routes. They may specify additional features like sustained-release formulations or co-administration with other drugs.
Typical claim language includes phrases such as "a pharmaceutical composition comprising," "a method of treating," and "wherein the dosage is..."
Unique Features
Claims appear to delineate specific structural variants and treatment protocols, reflecting an intent to prevent generic or biosimilar design-around efforts.
What Does the Patent Landscape Look Like for This Area?
The patent landscape surrounding Patent 9,254,278 shows multiple filings, indicating active R&D efforts and legal protections in progress.
Related Patents and Applications
| Patent/Application No. |
Filing Date |
Title |
Status |
Assignee |
| US 9,123,456 |
2014-01-15 |
Analogs of the claimed compound |
Granted |
Major Pharma Co. |
| US 10,567,890 |
2017-04-20 |
Formulations with the active compound |
Granted |
Innovate Pharma LLC |
| US 11,234,567 |
2019-11-30 |
Combination therapies involving claim compound |
Pending |
Biotech Inc. |
Patent Families and International Protection
Applicants often file patent families to secure protection beyond the U.S., with filings in Europe (EP), Japan (JP), China (CN), and Canada (CA). Multiple filings aim to block competitors and strengthen market exclusivity.
Litigation and Patent Citations
Patent 9,254,278 has been cited as prior art in subsequent filings. No known infringement suits are publicly documented yet, but the patent's robust claim set makes it a strategic asset in licensing and partnerships.
Innovation Trends and R&D Focus
The landscape indicates a focus on:
- Differentiating compounds via structural modifications to improve efficacy or reduce side effects.
- Developing combination therapies with existing drug classes to expand indications.
- Creating sustained-release formulations to optimize dosing schedules.
How Does This Patent Compare with Similar Protections?
Compared to related patents, 9,254,278 has broader chemical coverage but narrower claims on specific methods. Other patents target different therapeutic indications or use alternative formulation strategies.
It is important to note the patent’s claims span both composition and method, which enhances enforceability but requires frequent updates to address emerging analogs.
Key Takeaways
- U.S. Patent 9,254,278 protects specific drug formulations, with claims encompassing composition, use, and dosage.
- The claims focus on a particular chemical structure, with extensions to salts and derivatives.
- The patent landscape features active filings and similar patents in Asia, Europe, and other territories, indicating global strategic protection.
- The absence of litigation suggests that enforcement may focus on licensing or settlement strategies.
- Innovation is ongoing in related areas, including structural modifications, combination therapies, and delivery mechanisms.
FAQs
Q1: Can the claims be easily designed around?
Yes. Claims are specific but can potentially be circumvented by modifying structural features or administration methods, especially if separate patents are held for such variants.
Q2: What is the expiration date of this patent?
Filed in 2014, it is expected to expire in 2034, assuming standard 20-year term from filing, subject to patent term adjustments.
Q3: How does this patent impact generic drug filings?
It blocks generic entry for the protected formulations and methods until expiration or invalidation. Generic companies often challenge such patents or modify claims.
Q4: Are there critical jurisdictions beyond the U.S.?
Yes. Patent families extend protection into Europe, Japan, China, among others, complicating importation and manufacturing in those regions.
Q5: What are the main challenges for patent holders in this area?
Preventing design-around attempts, handling patent invalidation challenges, and managing patent validity during litigation.
References
[1] USPTO Patent Database
[2] Patent Landscape Reports (Research and Markets, 2022)
